Archives

by in
Entry Author Date Location
Genomic Health Test Aims To Cut Overtreatment of Prostate Cancer 05/08/13 San Francisco
Why Are Healthcare Costs Exploding? See Proton Cancer Therapy 03/18/13 National
Prostate Cancer Drug Winners and Losers at ASCO GU 02/15/13 National
Tokai Looks to Follow Fast Behind J&J, Medivation in Prostate Cancer 02/13/13 Boston
FDA Approves First Drug for Exelixis of South San Francisco 11/29/12 San Francisco
Medivation Wins FDA Approval of Prostate Cancer Drug 08/31/12 San Francisco
Richard Brewer, Former Scios CEO and Dendreon Chairman, Dies at 61 08/15/12 San Francisco
Dendreon Cutting 600 Jobs, Closing NJ Plant As Sales Fall Short 07/30/12 Seattle
Dendreon Shareholders Vent at Annual Meeting 06/13/12 Seattle
Bayer Oncology Dubs ASCO “Turning Point” for Cancer Efforts 06/06/12 New York
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
Medivation Emerges With New Prostate Cancer Drug 05/31/12 San Francisco
Dendreon’s Provenge Works Best for Patients With Low PSA, Scientists Say 05/16/12 Seattle
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
Dendreon CEO John Johnson: ‘This is My Last Stop’ 04/17/12 Seattle
OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up 03/08/12 Seattle
San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers 03/06/12 San Diego
Dendreon Adds ImClone Vets to New Management Team 02/28/12 Seattle
SD Life Sciences Roundup: Celladon, Gen-Probe, Organovo, and More 02/16/12 National
FDA Approves New Gen-Probe Test for Men at Risk of Prostate Cancer 02/15/12 San Diego
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership 01/17/12 San Francisco
Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms 01/05/12 Seattle
Dendreon Edges Past Street Expectations With Third Quarter Provenge Sales, Shares Still Fall 11/02/11 Seattle
Exelixis To Push Ahead on Prostate Cancer Trial Without FDA Agreement: Shares Plunge 10/31/11 San Francisco
Exelixis Passes Key Test With Lead Drug; Stock Soars 10/24/11 San Francisco
Mascoma Seeks IPO, Tokai Takes in $23M, Boston-Power Gets $125 for Shift to China, & More Boston-Area Deals News 09/21/11 Boston
Dendreon Concentrates Job Cuts in Manufacturing, but Seattle Feels the Axe Too 09/08/11 Seattle
Dendreon Whacks 500 Jobs, 25% of Workforce, After Missing Sales Goal 09/08/11 Seattle
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News 09/08/11 Seattle
Dendreon Wins FDA OK for Atlanta Provenge Factory, Completing National Network 08/26/11 Seattle
Page 1 of 7 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.